A Role for a Helical Connector between Two Receptor Binding Sites of a Long-chain Peptide Hormone

• Published in: The Journal of biological chemistry 2000-02, Vol.275 (8), p.5702-5709
• Main Authors: Beyermann, Michael, Rothemund, Sven, Heinrich, Nadja, Fechner, Klaus, Furkert, Jens, Dathe, Margitta, Winter, Rüdiger, Krause, Eberhard, Bienert, Michael
• Format: Article
• Language: English
• Subjects: Adrenocorticotropic Hormone - metabolism; Amino Acid Sequence; Animals; Binding Sites; Brain - metabolism; Circular Dichroism; Corticotropin-Releasing Hormone - chemistry; Corticotropin-Releasing Hormone - pharmacology; Dose-Response Relationship, Drug; Kinetics; Leydig Cells - metabolism; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Sequence Data; Peptides; Pituitary Gland, Anterior - metabolism; Protein Conformation; Protein Structure, Secondary; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone - chemistry; Sequence Homology, Amino Acid; Testosterone - biosynthesis; Testosterone - pharmacology; Urocortins
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.275.8.5702

The conformational freedom of single-chain peptide hormones, such as the 41-amino acid hormone corticotropin releasing factor (CRF), is a major obstacle to the determination of their biologically relevant conformation, and thus hampers insights into the mechanism of ligand-receptor interaction. Since N- and C-terminal truncations of CRF lead to loss of biological activity, it has been thought that almost the entire peptide is essential for receptor activation. Here we show the existence of two segregated receptor binding sites at the N and C termini of CRF, connection of which is essential for receptor binding and activation. Connection of the two binding sites by highly flexible ε-aminocaproic acid residues resulted in CRF analogues that remained full, although weak agonists (EC50: 100–300 nm) independent of linker length. Connection of the two sites by an appropriate helical peptide led to a very potent analogue, which adopted, in contrast to CRF itself, a stable, monomer conformation in aqueous solution. Analogues in which the two sites were connected by helical linkers of different lengths were potent agonists; their significantly different biopotencies (EC50: 0.6–50 nm), however, suggest the relative orientation between the two binding sites rather than the maintenance of a distinct distance between them to be essential for a high potency.